Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Angiotensin Converting Enzyme Inhibitors market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Angiotensin Converting Enzyme Inhibitorsmarket, defines the market attractiveness level of Angiotensin Converting Enzyme Inhibitors market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Angiotensin Converting Enzyme Inhibitors industry, describes the types of Angiotensin Converting Enzyme Inhibitors market, the applications of major players and the market size, and deeply analyzes the current situation of the global Angiotensin Converting Enzyme Inhibitors market and the development prospects and opportunities of Angiotensin Converting Enzyme Inhibitors industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Angiotensin Converting Enzyme Inhibitors market in Chapter 13.
By Player:
Pfizer
Daiichi Sankyo
Merck
Sanofi
Abbott
Novartis AG
AstraZeneca
By Type:
Benazepril (Lotensin)
Captopril
Enalapril (Vasotec)
Fosinopril
Lisinopril (Prinivil
Zestril)
Moexipril
Perindopril
Quinapril (Accupril)
Ramipril (Altace)
Trandolapril
By End-User:
Coronary Artery Disease
Heart Failure
Diabetes
Chronic Kidney Diseases
Heart Attacks
Scleroderma
Migraines
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Angiotensin Converting Enzyme Inhibitors Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Angiotensin Converting Enzyme Inhibitors Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Angiotensin Converting Enzyme Inhibitors Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Angiotensin Converting Enzyme Inhibitors Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Angiotensin Converting Enzyme Inhibitors Market Analysis and Outlook to 2022
-
7.1 Global Angiotensin Converting Enzyme Inhibitors Consumption (2017-2022)
-
7.2 United States Angiotensin Converting Enzyme Inhibitors Consumption (2017-2022)
-
7.3 Europe Angiotensin Converting Enzyme Inhibitors Consumption (2017-2022)
-
7.4 China Angiotensin Converting Enzyme Inhibitors Consumption (2017-2022)
-
7.5 Japan Angiotensin Converting Enzyme Inhibitors Consumption (2017-2022)
-
7.6 India Angiotensin Converting Enzyme Inhibitors Consumption (2017-2022)
-
7.7 South Korea Angiotensin Converting Enzyme Inhibitors Consumption (2017-2022)
8 Region and Country-wise Angiotensin Converting Enzyme Inhibitors Market Analysis and Outlook to 2028
-
8.1 Global Angiotensin Converting Enzyme Inhibitors Consumption Forecast (2022-2028)
-
8.2 United States Angiotensin Converting Enzyme Inhibitors Consumption Forecast (2022-2028)
-
8.3 Europe Angiotensin Converting Enzyme Inhibitors Consumption Forecast (2022-2028)
-
8.4 China Angiotensin Converting Enzyme Inhibitors Consumption Forecast (2022-2028)
-
8.5 Japan Angiotensin Converting Enzyme Inhibitors Consumption Forecast (2022-2028)
-
8.6 India Angiotensin Converting Enzyme Inhibitors Consumption Forecast (2022-2028)
-
8.7 South Korea Angiotensin Converting Enzyme Inhibitors Consumption Forecast (2022-2028)
9 Global Angiotensin Converting Enzyme Inhibitors Market Outlook by Types and Applications to 2022
-
9.1 Global Angiotensin Converting Enzyme Inhibitors Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Benazepril (Lotensin) Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Captopril Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Enalapril (Vasotec) Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Fosinopril Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Lisinopril (Prinivil Consumption and Growth Rate (2017-2022)
-
9.1.6 Global Zestril) Consumption and Growth Rate (2017-2022)
-
9.1.7 Global Moexipril Consumption and Growth Rate (2017-2022)
-
9.1.8 Global Perindopril Consumption and Growth Rate (2017-2022)
-
9.1.9 Global Quinapril (Accupril) Consumption and Growth Rate (2017-2022)
-
9.1.10 Global Ramipril (Altace) Consumption and Growth Rate (2017-2022)
-
9.1.11 Global Trandolapril Consumption and Growth Rate (2017-2022)
-
9.2 Global Angiotensin Converting Enzyme Inhibitors Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Coronary Artery Disease Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Heart Failure Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Diabetes Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Chronic Kidney Diseases Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Heart Attacks Consumption and Growth Rate (2017-2022)
-
9.2.6 Global Scleroderma Consumption and Growth Rate (2017-2022)
-
9.2.7 Global Migraines Consumption and Growth Rate (2017-2022)
-
9.2.8 Global Others Consumption and Growth Rate (2017-2022)
10 Global Angiotensin Converting Enzyme Inhibitors Market Outlook by Types and Applications to 2028
-
10.1 Global Angiotensin Converting Enzyme Inhibitors Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Benazepril (Lotensin) Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Captopril Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Enalapril (Vasotec) Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Fosinopril Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Lisinopril (Prinivil Consumption Forecast and Growth Rate (2022-2028)
-
10.1.6 Global Zestril) Consumption Forecast and Growth Rate (2022-2028)
-
10.1.7 Global Moexipril Consumption Forecast and Growth Rate (2022-2028)
-
10.1.8 Global Perindopril Consumption Forecast and Growth Rate (2022-2028)
-
10.1.9 Global Quinapril (Accupril) Consumption Forecast and Growth Rate (2022-2028)
-
10.1.10 Global Ramipril (Altace) Consumption Forecast and Growth Rate (2022-2028)
-
10.1.11 Global Trandolapril Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Angiotensin Converting Enzyme Inhibitors Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Coronary Artery Disease Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Heart Failure Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Diabetes Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Chronic Kidney Diseases Consumption Forecast and Growth Rate (2022-2028)
-
10.2.5 Global Heart Attacks Consumption Forecast and Growth Rate (2022-2028)
-
10.2.6 Global Scleroderma Consumption Forecast and Growth Rate (2022-2028)
-
10.2.7 Global Migraines Consumption Forecast and Growth Rate (2022-2028)
-
10.2.8 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Angiotensin Converting Enzyme Inhibitors Import and Export Analysis (Top 5 Countries)
-
11.1 Global Angiotensin Converting Enzyme Inhibitors Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Angiotensin Converting Enzyme Inhibitors Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Angiotensin Converting Enzyme Inhibitors Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Angiotensin Converting Enzyme Inhibitors Market Competitive Analysis
-
14.1 Pfizer
-
14.1.1 Pfizer Company Details
-
14.1.2 Pfizer Angiotensin Converting Enzyme Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Pfizer Angiotensin Converting Enzyme Inhibitors Product and Service
-
14.2 Daiichi Sankyo
-
14.2.1 Daiichi Sankyo Company Details
-
14.2.2 Daiichi Sankyo Angiotensin Converting Enzyme Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Daiichi Sankyo Angiotensin Converting Enzyme Inhibitors Product and Service
-
14.3 Merck
-
14.3.1 Merck Company Details
-
14.3.2 Merck Angiotensin Converting Enzyme Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Merck Angiotensin Converting Enzyme Inhibitors Product and Service
-
14.4 Sanofi
-
14.4.1 Sanofi Company Details
-
14.4.2 Sanofi Angiotensin Converting Enzyme Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Sanofi Angiotensin Converting Enzyme Inhibitors Product and Service
-
14.5 Abbott
-
14.5.1 Abbott Company Details
-
14.5.2 Abbott Angiotensin Converting Enzyme Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Abbott Angiotensin Converting Enzyme Inhibitors Product and Service
-
14.6 Novartis AG
-
14.6.1 Novartis AG Company Details
-
14.6.2 Novartis AG Angiotensin Converting Enzyme Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Novartis AG Angiotensin Converting Enzyme Inhibitors Product and Service
-
14.7 AstraZeneca
-
14.7.1 AstraZeneca Company Details
-
14.7.2 AstraZeneca Angiotensin Converting Enzyme Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 AstraZeneca Angiotensin Converting Enzyme Inhibitors Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Angiotensin Converting Enzyme Inhibitors
-
Figure Angiotensin Converting Enzyme Inhibitors Picture
-
Table Global Angiotensin Converting Enzyme Inhibitors Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Angiotensin Converting Enzyme Inhibitors Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Angiotensin Converting Enzyme Inhibitors Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Angiotensin Converting Enzyme Inhibitors Consumption by Country (2017-2022)
-
Figure United States Angiotensin Converting Enzyme Inhibitors Consumption and Growth Rate (2017-2022)
-
Table Europe Angiotensin Converting Enzyme Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure China Angiotensin Converting Enzyme Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Japan Angiotensin Converting Enzyme Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure India Angiotensin Converting Enzyme Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure South Korea Angiotensin Converting Enzyme Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global Angiotensin Converting Enzyme Inhibitors Consumption Forecast by Country (2022-2028)
-
Figure United States Angiotensin Converting Enzyme Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Angiotensin Converting Enzyme Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Angiotensin Converting Enzyme Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Angiotensin Converting Enzyme Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Angiotensin Converting Enzyme Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Angiotensin Converting Enzyme Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Benazepril (Lotensin) Consumption and Growth Rate (2017-2022)
-
Figure Global Captopril Consumption and Growth Rate (2017-2022)
-
Figure Global Enalapril (Vasotec) Consumption and Growth Rate (2017-2022)
-
Figure Global Fosinopril Consumption and Growth Rate (2017-2022)
-
Figure Global Lisinopril (Prinivil Consumption and Growth Rate (2017-2022)
-
Figure Global Zestril) Consumption and Growth Rate (2017-2022)
-
Figure Global Moexipril Consumption and Growth Rate (2017-2022)
-
Figure Global Perindopril Consumption and Growth Rate (2017-2022)
-
Figure Global Quinapril (Accupril) Consumption and Growth Rate (2017-2022)
-
Figure Global Ramipril (Altace) Consumption and Growth Rate (2017-2022)
-
Figure Global Trandolapril Consumption and Growth Rate (2017-2022)
-
Figure Global Coronary Artery Disease Consumption and Growth Rate (2017-2022)
-
Figure Global Heart Failure Consumption and Growth Rate (2017-2022)
-
Figure Global Diabetes Consumption and Growth Rate (2017-2022)
-
Figure Global Chronic Kidney Diseases Consumption and Growth Rate (2017-2022)
-
Figure Global Heart Attacks Consumption and Growth Rate (2017-2022)
-
Figure Global Scleroderma Consumption and Growth Rate (2017-2022)
-
Figure Global Migraines Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Benazepril (Lotensin) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Captopril Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Enalapril (Vasotec) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Fosinopril Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Lisinopril (Prinivil Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Zestril) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Moexipril Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Perindopril Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Quinapril (Accupril) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Ramipril (Altace) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Trandolapril Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Coronary Artery Disease Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Heart Failure Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Diabetes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Chronic Kidney Diseases Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Heart Attacks Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Scleroderma Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Migraines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Angiotensin Converting Enzyme Inhibitors Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Angiotensin Converting Enzyme Inhibitors Export by Region (Top 5 Countries) (2017-2028)
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Angiotensin Converting Enzyme Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Angiotensin Converting Enzyme Inhibitors Product and Service
-
Table Daiichi Sankyo (Foundation Year, Company Profile and etc.)
-
Table Daiichi Sankyo Angiotensin Converting Enzyme Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Daiichi Sankyo Angiotensin Converting Enzyme Inhibitors Product and Service
-
Table Merck (Foundation Year, Company Profile and etc.)
-
Table Merck Angiotensin Converting Enzyme Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Angiotensin Converting Enzyme Inhibitors Product and Service
-
Table Sanofi (Foundation Year, Company Profile and etc.)
-
Table Sanofi Angiotensin Converting Enzyme Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Angiotensin Converting Enzyme Inhibitors Product and Service
-
Table Abbott (Foundation Year, Company Profile and etc.)
-
Table Abbott Angiotensin Converting Enzyme Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Abbott Angiotensin Converting Enzyme Inhibitors Product and Service
-
Table Novartis AG (Foundation Year, Company Profile and etc.)
-
Table Novartis AG Angiotensin Converting Enzyme Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis AG Angiotensin Converting Enzyme Inhibitors Product and Service
-
Table AstraZeneca (Foundation Year, Company Profile and etc.)
-
Table AstraZeneca Angiotensin Converting Enzyme Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca Angiotensin Converting Enzyme Inhibitors Product and Service
-
